SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources
|
|
- Darren Daniel
- 8 years ago
- Views:
Transcription
1 SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services Administration 1
2 Overview National Survey Trends Reducing Demand Through Treatment Prevention-Related Activities Consumer Awareness - SMartRx Practitioner Education/Training Opioid Treatment Methadone Buprenorphine
3 Is prescription drug abuse a problem? National Survey on Drug Use and Health NSDUH, formerly national household survey. Drug Abuse Warning Network DAWN Emergency Department Medical Examiner Monitoring the Future
4 2007 NSDUH Highlights Among youth ages 12-17, there was a significant decline in overall past month illicit drug use, from 11.6 percent in 2002 to 9.5 percent in Reductions in youth drug use occurred for nearly every type of illicit drug, including marijuana, cocaine, hallucinogens, LSD, Ecstasy, prescription-type drugs used nonmedically, pain relievers, stimulants and methamphetamine. Despite many positive trends, the most recent NSDUH also reveals some less encouraging data. Among young adults ages 18 to 25, the level of current nonmedical use of prescription pain relievers has risen 12 percent (to 4.6 percent in 2007). In addition, the level of current illicit drug use among those aged 55 to 59 more than doubled, to 4.1 percent in 2007, confirming concerns that baby boomers have continued their higher levels of substance abuse as they age.
5 Fig 2.1 Past Month Illicit Drug Use among Persons Aged 12 or Older: 2007 Illicit Drugs 19.9 Marijuana Psychotherapeutics 6.9 Cocaine 2.1 Hallucinogens Inhalants Heroin Numbers in Millions 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically.
6 Fig 2.2 Past Month Use of Selected Illicit Drugs among Persons Aged 12 or Older: Percent Using in Past Month Illicit Drugs Marijuana Cocaine Methamphetamine Difference between this estimate and the 2007 estimate is statistically significant at the.05 level Psychotherapeutics Pain Relievers
7 Past Month Nonmedical Use of Pain Relievers among Persons Aged 12 or Older, by Age: Percent Using in Past Month to to or Older Difference between this estimate and the 2007 estimate is statistically significant at the.05 level.
8 Fig 5.1 Specific Drug Used When Initiating Illicit Drug Use among Past Year Initiates of Illicit Drugs Aged 12 or Older: 2007 Pain Relievers 19.0% Marijuana 56.2% Inhalants 10.7% Tranquilizers 6.5% Stimulants 4.1% Hallucinogens 2.0% Cocaine 0.6% Sedatives 1.1% 2.7 Million Initiates of Illicit Drugs Note: The percentages add to greater than 100 percent because of a small number of respondents initiating multiple drugs on the same day.
9 Fig 5.2 Past Year Initiates for Specific Illicit Drugs among Persons Aged 12 or Older: 2007 Numbers in Thousands 2,500 2,147 2,090 2,000 1,500 1, , Marijuana Cocaine Inhalants LSD Heroin Pain Tranquilizers Ecstasy Center Stimulants for Substance Sedatives Abuse Treatment PCP Relievers
10 Past Year Initiates for Specific Illicit Drugs among Persons Aged 12 or Older: Numbers in Thousands 3,000 2,500 2,000 2,320 2,196 2, ,973 2,422 2,142 2,193 2,114 2,150 2,063 2,147 2,090 Pain Relievers Marijuana 1,500 1, Difference between this estimate and the 2007 estimate is statistically significant at the.05 level.
11 Fig 5.3 Mean Age at First Use for Specific Illicit Drugs among Past Year Initiates Aged 12 to 49: 2007 Age in Years Inhalants LSD Ecstasy Heroin Sedatives PCP Marijuana Cocaine Pain Center for Substance Stimulants Abuse Tranquilizers Treatment Relievers
12 Fig 7.2 Dependence on or Abuse of Specific Illicit Drugs in the Past Year among Persons Aged 12 or Older: 2007 Marijuana 3,932,000 Pain Relivers 1,707,000 Cocaine 1,598,000 Tranquilizers Stimulants Hallucinogens Heroin Inhalants Sedatives 443, , , , , , ,000,000 2,000,000 Center for 3,000,000 Substance 4,000,000 Abuse Treatment 5,000,000 Substance Numbers Abuse of and Persons Mental with Health Drug Use Services Disorder Administration
13 Nonmedical Use of Pharmaceuticals, Selected Opiates/Opioids, 2006 Visits (thousands) CI upper bound estimate CI lower bound Fentanyl* Hydrocodone* Morphine* Oxycodone* * Single- & multi-ingredient formulations Source: National Substance estimates from Abuse DAWN, and Mental 2006 Health Services Administration
14 Nonmedical Use of Pharmaceuticals, Selected Opiates/Opioids, 2006 Visits (thousands) Opiates/opioids not specified CI upper bound estimate CI lower bound Methadone Buprenorphine* * Single- & multi-ingredient formulations Source: National Substance estimates from Abuse DAWN, and Mental 2006 Health Services Administration
15 Nonmedical Use of Pain Relievers in the Past Year among Persons Aged 12 or Older, by Substate Region*: Percentages, Annual Averages Based on 2004, 2005, and 2006 NSDUHs
16 Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2007 Source Where Respondent Obtained Drug Dealer/ Stranger 4.1% More than One Doctor 2.6% One Doctor 18.1% Bought/Took from Friend/Relative 14.1% Bought on Internet 0.5% Other 1 4.2% Free from Friend/Relative 56.5% Source Where Friend/Relative Obtained One Doctor 81.0% More than One Doctor 2.9% Free from Friend/Relative 6.6% Other 1 1.8% Bought/Took from Friend/Relative 5.9% Drug Dealer/ Stranger 1.8% Bought on Internet 0.1% Note: Totals may not sum to 100% because of rounding or because suppressed estimates are not shown. 1 The Other category includes the sources "Wrote Fake Prescription," "Stole from Doctor s Office/Clinic/Hospital/Pharmacy," and "Some Other Way."
17 Response to Rx Drug Abuse Substance abuse treatment Block Grant Treatment Vouchers Provider screening, intervention Opioid Assisted Treatment Methadone Buprenorphine Provider education/training Consumer education/awareness
18 Fig 7.7 Past Year Perceived Need for and Effort Made to Receive Specialty Treatment among Persons Aged 12 or Older Needing But Not Receiving Treatment for Illicit Drug or Alcohol Use: 2007 Did Not Feel They Needed Treatment (19.5 m) 93.6% 4.6% Felt They Needed Treatment and Did Not Make an Effort (955,000) 1.8% Felt They Needed Treatment and Did Make an Effort (380,000) 20.8 Million Needing But Not Receiving Treatment for Illicit Drug or Alcohol Use
19 Fig 7.8 Reasons for Not Receiving Substance Use Treatment among Persons Aged 12 or Older Who Needed and Made an Effort to Get Treatment But Did Not Receive Treatment and Felt They Needed Treatment: Combined No Health Coverage and Could Not Afford Cost Not Ready to Stop Using Able to Handle Problem without Treatment No Transportation/Inconvenient Might Cause Neighbors/Community to Have Negative Opinion No Program Having Type of Treatment Might Have Negative Effect on Job Did Not Know Where to Go for Treatment Substance Abuse and Mental Percent Health Reporting Services Reason Administration
20 Reimbursing for SBI in Health Care Settings HCPCS Codes (Medicaid) - H0049: Alcohol &/or Drug Screening ($24) - H0050: Brief Intervention:15 mins. ($48) CMS G-Codes (Medicare) - G0396: mins ($29.42) - G0397: > 30 mins ($57.69) CPT Codes (Commercial Health Plans) : mins ($33.41) : > 30 mins ($65.51)
21 Treatment for Opioid Dependence Drug Free, residential, in patient, ambulatory Medication Assisted Treatment Clonidine Naltrexone Opioid Assisted Treatment Methadone Buprenorphine
22 Methadone Maintenance Regulated by DEA, State, local Treatment programs 1200 programs 260,000 patients Public non profit Private for profit Stigmatized
23 Risk Management for Methadone Pain Treatment no required Risk management plan FDA modified labeling, 2006 DEA voluntary restriction on distribution 2008 Addiction/Dependence Treatment Distribution limited to certified, accredited, registered programs Initial dose limit Restrictions on dispensing
24 Methadone In Opioid Dependence Treatment Risk Management Training Guideances to field New Guidelines Dear Colleague Letters Induction practices Patient death reporting State Activities West Virginia moratorium, PDMP check on all patients,
25 Office-based opioid addiction treatment - Buprenorphine 2000 Federal Law permits certain physicians to prescribe certain narcotic medications for opioid dependence
26 Physician Eligibility/Restrictions Physicians Medical license DEA Registration Qualifications Credentialing 8 hour training Restrictions Certain medications Suboxone/Subutex Patient limits 30 or 100
27 Total Number of Patients that Filled a Prescription for Suboxone and Subutex in U.S. Retail Pharmacies, Patient Count (Thousands) SUBOXONE SUBUTEX Year Source: Verispan Total Patient Tracker, Extracted Feb. 2008
28 Buprenorphine Treatment and Diversion 16,000 certified physicians more in 2008 then any other year 305,000 patients in 2007 Baltimore Sun Buprenorphine diverted Buprenorphine injected Buprenorphine and poison reports Buprenorphine related deaths French experience with buprenorphine
29 Prescriber Education and Training
30 Physician Education 4-8 Hour CME Problems we see with patients who are prescribed opioids for persistent pain Deciding whether or not to prescribe an opioid Pharmacology, emphasis on methadone Steps to take if you decide to use opioids in the treatment of persistent pain Steps to take if you decide NOT to use opioids in the treatment of persistent pain: The practical side of patient monitoring PMP, screening, lost Rx, etc. When, why and how to stop prescribing opioids and manage the patient with another treatment approach
31 Opioid Prescribing CME Planned with State Medical Society Pilot tested in Ohio, Virginia Offered in West Virginia (2), Massachusetts, Connecticut, North Carolina, Florida, Maine Integrate with online tie to registration renewal
32 Consumer Awareness/Prevention SmartRx risks, precautions, disposal information on controlled prescription medications distributed to patients point of sale (pharmacy)
33 Program Overview The program ran from 10/22/07 to 5/1/08. The core of the program sent targeted PatientLink messages to patients picking up the following categories of prescriptions: Select Hydrocodones, Benzodiazepines, Sleep Aids, and Oxycontin. The above messages were communicated with patients in the following states as per the government study on abuse rates: AR, AZ, CA, CO, ID, IN, KY, LA, MA, MI, MN, MT, NC, NH, NM, NV, OK, OR, RI, SC, TN, UT, WA, WI, WV, WY. This state criteria allowed Catalina to use approximately 6,300 of its 15,000 pharmacies for distribution (2007 count). In addition to the above prints, the program included a PharmAware message. This message was communicated to over 75,000 pharmacists in the network. The message printed six different times over 12 days to achieve this reach. This execution occurred during Center November for Substance Abuse Treatment 33
34 Program Overview SAMHSA PatientLi 34
35 PatientLink Delivers Trusted Results Based on the Catalina 2007 Readership Study Only physicians and pharmacists are seen as providing more trustworthy information than the PatientLink TM messages. Your physician A pharmacist Information attached to or included w/ prescription A nurse at your physician's office Web site about specific brand of medication Web site about specific med. condition from nonprofit/ govt. Web site about med. condition sponsored by pharma. co. Literature/brochures distributed in aisles of pharmacy Mail sent to my home, sponsored by a pharma. co. Info sent via , sponsored by a pharma. co. Ad in magazine about medication TV ad about medication
36 Summary Prescription drug abuse increasing public health problem Buprenorphine and methadone treatment expanding Rx Opioid/Methadone mortality Labeling, guidance, education, voluntary distribution restriction
Prescription Drug Abuse and NASPER Harold Rogers Prescription Drug Monitoring Program June 30, 2010 Washington, DC
Prescription Drug Abuse and NASPER Harold Rogers Prescription Drug Monitoring Program June 30, 2010 Washington, DC Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services
More informationPrescription Drug Abuse: Recognition, Intervention, and Prevention
Prescription Drug Abuse: Recognition, Intervention, and Prevention Nicholas Reuter Division of Pharmacologic Therapy Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration
More informationDriving under the influence of alcohol or
National Survey on Drug Use and Health The NSDUH Report December 9, 2010 State Estimates of Drunk and Drugged Driving In Brief Combined 2006 to 2009 data indicate that 13.2 percent of persons aged 16 or
More informationMassachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
More informationPrescriber Behavior, Pain Treatment and Addiction Treatment
Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP
More informationAn integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 Background Defining the problem: Opiates pain relievers (OxyContin,
More informationPrescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth
Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us
More informationTRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013
2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,
More informationVIRGINIA S PRESCRIPTION MONITORING PROGRAM
VIRGINIA S PRESCRIPTION MONITORING PROGRAM A Resource for Patient Management with Controlled Substances 2,500 Past Year Initiates of Specific Illicit Drugs among Persons Aged 12 or Older: 2009 Numbers
More informationThe Prescrip+on Drug Abuse Epidemic and Preven+on: How Prescrip+on Monitoring Programs Can Help
The Prescrip+on Drug Abuse Epidemic and Preven+on: How Prescrip+on Monitoring Programs Can Help PMP Center of Excellence at Brandeis University September 23, 2010 Webinar Learning Objec+ves To understand
More informationBehavioral Health Barometer. Virginia, 2014
Behavioral Health Barometer Virginia, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No. 283
More informationBehavioral Health Barometer. United States, 2014
Behavioral Health Barometer United States, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
More informationSouth Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives
South Dakota Prescription Drug Monitoring Program (SD PDMP) SD Academy of Physician Assistants Summer/Fall CME Conference September 6, 2012 Ron Huether, RPh, SD PDMP Kari Shanard Koenders, RPh, PDMP Director
More informationBehavioral Health Barometer. Oklahoma, 2014
Behavioral Health Barometer Oklahoma, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No. 283
More informationU.S. Food and Drug Administration
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained
More informationBehavioral Health Barometer. Mississippi, 2014
Behavioral Health Barometer Mississippi, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
More informationDEA Update on Regulations and Enforcement. Michael J. Lewis Diversion Program Manager Los Angeles Field Division
DEA Update on Regulations and Enforcement Michael J. Lewis Diversion Program Manager Los Angeles Field Division 1 Learning Objectives Describe the mission of the Office of Diversion Control Discuss the
More informationSubstance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
More informationPRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
More informationPrescription for Danger
Prescription for Danger A Report on the Troubling Trend of Prescription and Over-the-Counter Drug Abuse Among the Nation s Teens OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT
More informationStates In Brief Substance Abuse and Mental Health Issues At-A-Glance
virginia States In Brief Substance Abuse and Mental Health Issues At-A-Glance a Short report from the Office of applied Studies Prevalence of Illicit Substance 1 and Alcohol Use The National Survey on
More informationINFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State
ADAI-IB 23-3 INFO Brief Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State O ctober 23 Caleb Banta-Green (Alcohol and Drug Abuse Institute, University of Washington),
More informationStates In Brief. The National Survey on Drug Use and Health. texas. Prevalence of Illicit Substance 1 and Alcohol Use
texas States In Brief Substance Abuse and Mental Health Issues At-A-Glance a short Report from the Office of applied studies Prevalence of Illicit Substance 1 and Alcohol Use The National Survey on Drug
More informationTEENS AND PRESCRIPTION DRUGS An Analysis of Recent Trends on the Emerging Drug Threat
TEENS AND PRESCRIPTION DRUGS An Analysis of Recent Trends on the Emerging Drug Threat OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT FEBRUARY 2007 TABLE OF CONTENTS Introduction
More informationSubstance Abuse Treatment Admissions for Abuse of Benzodiazepines
Treatment Episode Data Set The TEDS Report June 2, 2011 Substance Abuse Treatment Admissions for Abuse of Benzodiazepines Benzodiazepines are a class of central nervous system depressant drugs that are
More informationSubstance Abuse Prevention and Treatment Agency March, 2012
Substance Abuse Prevention and Treatment Agency March, 2012 1 The mission of the Substance Abuse Prevention and Treatment Agency (SAPTA) is to reduce the impact of substance abuse in Nevada. SAPTA funds
More informationSubstance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008
Treatment Episode Data Set The TEDS Report July 15, 010 Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 008 In Brief The proportion of all substance abuse treatment admissions
More informationStates In Brief Substance Abuse and Mental Health Issues At-A-Glance
kentucky States In Brief Substance Abuse and Mental Health Issues At-A-Glance A Short Report from the Office of Applied Studies Prevalence of Illicit Substance 1 and Alcohol Use The National Survey on
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationJane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture
Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational
More informationAs the proportion of racial/
Treatment Episode Data Set The TEDS Report May 5, 1 Differences in Substance Abuse Treatment Admissions between Mexican-American s and s As the proportion of racial/ ethnic minority groups within the United
More informationSouthlake Psychiatry. Suboxone Contract
Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to
More informationPRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES
PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES PART 1: STATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) PREPARED BY THE NATIONAL
More informationARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E
BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use
More informationBehavioral Health Barometer. United States, 2014
Behavioral Health Barometer United States, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
More informationBehavioral Health Barometer. New Jersey, 2013
Behavioral Health Barometer New Jersey, 2013 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationFighting Prescription Drug Abuse in Lake County: A Partnership In The Community Between The Citizens, Physicians, Pharmacies and Law Enforcement
Fighting Prescription Drug Abuse in Lake County: A Partnership In The Community Between The Citizens, Physicians, Pharmacies and Law Enforcement Presented by: Sgt. Chris Begley Lake County Narcotics Agency
More informationResults from the 2010 National Survey on Drug Use and Health: Summary of National Findings
Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings DISCLAIMER SAMHSA provides links to other Internet sites as a service to its users and is not responsible for
More informationThe Changing Face of Opioid Addiction:
9th Annual Training and Educational Symposium September 6, 2012 The Changing Face of Opioid Addiction: A Review of the Research and Considerations for Care Mark Stanford, Ph.D. Santa Clara County Dept
More informationBehavioral Health Barometer. United States, 2013
Behavioral Health Barometer United States, 2013 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
More informationPrescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices
Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices National Governors Association Policy Academy: Reducing Prescription Drug Abuse June 8, 2015 Burlington, VT Improving Interstate
More informationHow To Find Out If You Can Get Help For Your Drug Or Alcohol Problem
Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center
More informationAlaska (AK) Arizona (AZ) Arkansas (AR) California-RN (CA-RN) Colorado (CO)
Beth Radtke 50 Included in the report: 7/22/2015 11:15:28 AM Alaska (AK) Arizona (AZ) Arkansas (AR) California-RN (CA-RN) Colorado (CO) Connecticut (CT) Delaware (DE) District Columbia (DC) Florida (FL)
More informationMEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER
MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER TWO PRIMARY ACCESS POINTS Pharmacy Benefit Dispensed by a Pharmacy Billed via the PBM Process (NCPCP) Oversight by Drug
More informationPrescription Monitoring Programs: Creating a National Network
Prescription Monitoring Programs: Creating a National Network Danna E. Droz, JD, RPH PMP Liaison ddroz@nabp.net 847/391-4508 United States Drug Enforcement Administration National Conference on Pharmaceutical
More informationYouth Drug Abuse and Addiction
Youth Drug Abuse and Addiction Ken Winters, Ph.D. Dept. of Psychiatry, U. of Minnesota winte001@umn.edu Summit on Prescription Drug Abuse in Georgia March 2, 2011 1. Epidemiology of Rx Abuse by Youth 4.
More informationNational Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
More informationThe Current State of Drug Abuse Across the Nation. December 12, 2015
The Current State of Drug Abuse Across the Nation December 12, 2015 Agenda The Partnership for Drug-Free Kids The macro picture Opioid abuse and addiction What can we do about it? Moving upstream: connecting
More informationPrescription Drug Abuse in the US
TM The other epidemic: Prescription Drug Abuse in the US Ten prevention ideas from the states Len Paulozzi, MD, MPH National Center for Injury Prevention and Control Presented at the National Conference
More informationDrug Testing to Support Pain Management
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationCONNECTING FOR IMPACT: Federal Efforts to Integrate Health IT and PDMPs to Improve Patient Care
CONNECTING FOR IMPACT: Federal Efforts to Integrate Health IT and PDMPs to Improve Patient Care Jinhee Lee, PharmD Substance Abuse and Mental Health Services Administration Jennifer Frazier, MPH Office
More informationDrug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008
PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease
More informationBehavioral Health Indicators for Tennessee and the United States
Behavioral Health Indicators for Tennessee and the United States April 2015 Prepared by: Lymari Benitez, Ph.D. and Rachel L. Jones Tennessee Department of Mental Health and Substance Abuse Services Office
More informationHistory of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University
History of Prescription Drug Monitoring Programs PDMP Training and Technical Assistance Center Brandeis University History of Prescription Drug Monitoring Programs First PDMP Early PDMP Characteristics
More informationPRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES
PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES PART 3: PRESCRIBING OF CONTROLLED SUBSTANCES FOR NON-CANCER PAIN PREPARED BY THE
More informationTrends in Adult Female Substance Abuse Treatment Admissions Reporting Primary Alcohol Abuse: 1992 to 2007. Alcohol abuse affects millions of
Treatment Episode Data Set The TEDS Report January 7, 2010 Trends in Adult Female Substance Abuse Treatment Admissions Reporting Primary Alcohol Abuse: 1992 to 2007 In Brief Between 1992 and 2007, the
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationAnnual Harold Rogers Prescription Drug Monitoring Program onitoring. Commissioner Cheryl Bartlett, RN Massachusetts Department of Public Health
Annual Harold Rogers Prescription Drug Monitoring Program onitoring Commissioner Cheryl Bartlett, RN Massachusetts Department of Public Health Current Substance Use: Massachusetts vs. Northeast Region
More informationSigns of Substance Abuse in Broward County, Florida
Adult Summer 8 The chart below summarizes the severity and trends for indicators of drug use and abuse in Broward County, Florida. The Severity Index is based on the number of drug-related deaths, emergency
More information9/18/2013. Buprenorphine for Opioid Dependence: NIDA/SAMHSA Blending Initiative. According to the Webster Dictionary definition
2013 Annual Conference for Behavioral Health Wichita, Kansas September 18, 2013 Alex Barajas-Muñoz, MS Buprenorphine for Opioid Dependence: A Training for Multidisciplinary Addiction Professionals NIDA/SAMHSA
More informationSUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12
SUBOXONE /VIVITROL WEBINAR Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12 WEBINAR INTRODUCTIONS Cynthia Parsons- Program Manager
More informationWho provides this training? Are there any requirements? The parents/guardians and the doctor go through the medication curriculum with the student.
AL AK AZ AR Student, if they have a chronic condition school nurse or school administrators The student, if their parent/guardian authorizes them to. Trained school personnel can also administer Students
More informationMONTHLY VARIATION IN SUBSTANCE USE INITIATION AMONG FULL-TIME COLLEGE STUDENTS
Students College Full-Time Among Initiation Use Substance in Variation Monthly National Survey on Drug Use and Health Short Report August 27, 2015 MONTHLY VARIATION IN SUBSTANCE USE INITIATION AMONG FULL-TIME
More informationPopulations at risk for opioid overdose
Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April
More informationYoung Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers
Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers Audio will begin at 2:00 PM ET. You can listen through your computer
More informationFederation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Continuing Competence
This document reports CEU requirements for renewal. It describes: Number of required for renewal Who approves continuing education Required courses for renewal Which jurisdictions require active practice
More informationIn Brief UTAH. Adolescent Behavioral Health. A Short Report from the Office of Applied Studies
UTAH Adolescent Behavioral Health In Brief A Short Report from the Office of Applied Studies Adolescence (12 to 17 years) is a critical and vulnerable stage of human development, during which males and
More informationTestimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationMarijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century
Mother s little helper: Prescription drug abuse in the 21 st century Carol Falkowski CEO and Founder Drug Abuse Dialogues St. Paul, Minnesota www.drugabusedialogues.com More kids smoke marijuana than smoke
More informationPrescription Drug Monitoring Programs
Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics
More informationIn Brief MICHIGAN. Adolescent Behavioral Health. A Short Report from the Office of Applied Studies
MICHIGAN Adolescent Behavioral Health In Brief A Short Report from the Office of Applied Studies Adolescence (12 to 17 years) is a critical and vulnerable stage of human development, during which males
More informationPrescription Drug Abuse. Katherine E. Schmidt. IHEC Intern - Fall 2010
Disclaimer: The views of the author do not necessarily reflect the views and beliefs of the Illinois Higher Education Center, Eastern Illinois University, and The Department of Human Services. Prescription
More informationIn Brief ARIZONA. Adolescent Behavioral Health. A Short Report from the Office of Applied Studies
ARIZONA Adolescent Behavioral Health In Brief A Short Report from the Office of Applied Studies Adolescence (12 to 17 years) is a critical and vulnerable stage of human development, during which males
More information2013 CIGNA MEDICARE RX (PDP) A MEDICARE PRESCRIPTION DRUG PLAN
2013 CIGNA MEDICARE RX (PDP) A MEDICARE PRESCRIPTION DRUG PLAN 805978 i 08/12 S5617_5978i CMS Approved TABLE OF CONTENTS page Medicare overview 3 Medicare Part D 5 Cigna Medicare Rx (PDP) plans 12 Additional
More informationDashboard. Campaign for Action. Welcome to the Future of Nursing:
Welcome to the Future of Nursing: Campaign for Action Dashboard About this Dashboard: These are graphic representations of measurable goals that the Campaign has selected to evaluate our efforts in support
More informationAppendices to Interim Report on the Baltimore Buprenorphine Initiative. Managed Care Organization Information Pages
Appendices to Interim Report on the Baltimore Buprenorphine Initiative Appendix A Managed Care Organization Information Pages Appendix B Buprenorphine Online Physician Training Information Packet Appendix
More informationUse of Pharmacotherapies by Substance Abuse Treatment Facilities
Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1
More informationThe State of Prescription Drug Use in Georgia: A Needs Assessment
2012 The State of Prescription Drug Use in Georgia: A Needs Assessment Submitted By: Dr. Sheryl Strasser, Evaluator and Megan Smith, MPH, Assistant Evaluator Georgia State University, Institute of Public
More informationFederation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: License Renewal Who approves courses?
Federation of State s of Physical The table below provides information on approval of continuing education/competence courses and for each jurisdiction. Summary Number of jurisdictions requiring approval
More informationVermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations
Vermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations Vermont Prescription Drug Abuse Workgroup healthvermont.gov dps.vermont.gov Executive Summary In 2008 the Prescription Drug
More informationPrescription Drug Abuse in the Workplace
Prescription Drug Abuse in the Workplace Illicit drugs and misuse of alcohol are not the only substances that can affect health and safety in workplaces. Prescription drugs, when used without a prescription
More informationFederation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Continuing Competence
This document reports CEU (continuing education units) and CCU (continuing competence units) requirements for renewal. It describes: Number of CEUs/CCUs required for renewal Who approves continuing education
More informationResources for the Prevention and Treatment of Substance Use Disorders
Resources for the Prevention and Treatment of Substance Use Disorders Table of Contents Age-standardized DALYs, alcohol and drug use disorders, per 100 000 Age-standardized death rates, alcohol and drug
More informationDrug Enforcement Administration Office of Diversion Control. NFLIS Special Report Narcotic Analgesics, 2001 2003
Drug Enforcement Administration Office of Diversion Control N AT I O N A L FORENSIC L A B O R AT O R Y I N F O R M AT I O N June 24 Copyright www.streetdrugs.org NFLIS Special Report Narcotic Analgesics,
More informationLarry R. Kaiser, MD. President The University of Texas Health Science Center at Houston
Larry R. Kaiser, MD President The University of Texas Health Science Center at Houston HealthCare Workforce: UTHealth Experience CHALLENGE To train the Healthcare Workforce of the 21 st Century SOLUTIONS:
More informationINFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People
Product No. 2002-L0424-004 INFORMATION BRIEF AUGUST 2002 U. S. D E P A R T M E N T O F J U S T I C E NDIC and Stockbyte Overview Prescription drugs, a category of psychotherapeutics that comprises prescription-type
More informationResults from the 2013 National Survey on Drug Use and Health: Summary of National Findings
Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center
More informationPrescription Drug Abuse and Overdose: Public Health Perspective
Prescription Drug Abuse and Overdose: Public Health Perspective [Residency educators may use the following slides for their own teaching purposes.] CDC s Primary Care and Public Health Initiative October
More informationResults from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings
Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration
More informationPrescription Drug Monitoring Programs: A State Policy to Address Prescription Opioid Poisonings. Michael Kim, MPH April 30, 2012
Prescription Drug Monitoring Programs: A State Policy to Address Prescription Opioid Poisonings Michael Kim, MPH April 30, 2012 Overview 1. Prescription Opioid Abuse and Poisoning 2. Prescription Drug
More informationPractice Protocol. Buprenorphine Guidance Protocol
Practice Protocol Buprenorphine Guidance Protocol Developed by the Arizona Department of Health Services Division of Behavioral Health Services Effective Date: 02/23/11 Title Buprenorphine Guidance Protocol
More informationState Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry
State Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry Cliff Bersamira, Research Analyst Rick Harwood, Research and Program Applications Director National
More informationEXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org
EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org Disclosures Project Lazarus Zogenix Charitable Contribution 2015 Kaléo Charitable Contribution
More informationMedication is not a part of treatment.
Medication is not a part of treatment. Medication can be an effective part of treatment. Medication is used in the treatment of many diseases, including addiction. Medical decisions must be made by trained
More information